Today's presentation will be conducted in English and will consist of prepared remarks reviewing the group's financial and operational performance in 2025 and outlook for 2026. Following management's ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...
Duluth Holdings Inc. (NASDAQ:DLTH) Q4 2025 Earnings Call Transcript March 19, 2026 Duluth Holdings Inc. beats earnings expectations. Reported EPS is $0.23, expectations were $0.1464. Operator: Good ...
Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...
The following is the full transcript of the interview with International Atomic Energy Agency Director-General Rafael Grossi, ...
Historian Thomas Zimmer says Trump is still dangerous, but that his authoritarian project has been derailed on a number of fronts.
Nuwellis, Inc. beats earnings expectations. Reported EPS is $-1.4998, expectations were $-1.56. Operator: Thank you for your continued patience. Your meeting will begin shortly. If you need assistance ...
GAAP Net Income -- $110 million or $5.04 per share for the full year, reflecting a 175% increase. Adjusted Net Income -- $74 million or $3.04 per share for the full year, up $60 million, and a 429% ...
David Kostman: Thank you, Matt. Good morning, everyone, and thank you for joining us. About a year ago, we brought Outbrain and Teads Holding Co. together. The goal was and still is to build a best-in ...
Stuart Bodden: Thanks, Joe, and good morning, everyone. I appreciate all of you joining us today to discuss our fourth quarter and full year 2025 results. I will spend some time walking through our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results